PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Nifedipine - Angina
PAD Profile : Nifedipine - Angina Important
Keywords :
Branded prescribing, prescribing by brand, branded generics
Brand Names Include :
Adalat retard, Adalat LA, Adipine MR, Adipine XL, Coracten SR, Coracten XL, Nifedipress MR, Tensipin
Important Information :
Prescribe by BRAND.
Traffic Light Status
Status 1 of 2.
Status :
Green
Important
Formulations :
- Modified release tablets
Important Information :
Tensipine MR (Twice daily) and Adipine XL (once daily) are the preferred tablet brands.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Status 2 of 2.
Guidelines
No guidelines returned.
Other Drugs
- Isosorbide mononitrate
- Ivabradine
- Ranolazine
- Diltiazem hydrochloride
- Glyceryl trinitrate
- Amlodipine
- Verapamil hydrochloride
- Nicorandil
- Atenolol
- Bisoprolol fumarate
- Carvedilol
- Isosorbide dinitrate
- Metoprolol tartrate
- Propranolol hydrochloride
Other Indications
Additional Documents
Type
Document
Review Date
Committee Recommendations
Date
Committee Name
Narrative
02 October 2024
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
It is recommended that slow-release and longer-acting nifedipine products are prescribed by brand.
The preferred brands for use in primary care have been updated following the discontinuation of Adipine MR in August 2024.
The recommendations are now:
TWICE DAILY
- Coracten SR capsules OR
- Tensipine MR for patients preferring a tablet
ONCE DAILY
- Coracten XL capsules OR
- Adipine XL for patients preferring a tablet
Associated BNF Codes
02. Cardiovascular System
02.06.02. Calcium-channel blockers